Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Enhances Sample Preparation with New Syringe Filters

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Thermo Scientific Titan3 and Target2 syringe filters deliver reliability, reproducibility and flexibility.

Thermo Fisher Scientific Inc. has launched the Thermo Scientific Titan3 and Target2 ranges of single-use syringe filters for sample preparation.

These more robust syringe filters significantly enhance sample preparation workflow by accommodating greater burst pressures and providing exceptional flow-through characteristics.

Previously supplied as the SUN-Sri TITAN2 and National Scientific Target ranges, these filter units have been enhanced by Thermo Fisher to offer improved reliability and performance, including an improved housing design that prevents leakage during filtration.

The premium Titan3™ range provides further confidence with color-coded housings for easy membrane selection and an integral ring that withstands even greater burst pressures, with 30mm models resistant to pressures of up to 120psi.

Both the Titan3 and Target2™ filter ranges are fully HPLC-tested and incorporate low extractable membranes and housings.

Titan3 and Target2 syringe filters are available in a wide range of filtration membrane types and porosities and are suitable as a high-quality filtration solution for a range of chromatography filtration applications.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
Wednesday, October 24, 2012
Thermo Fisher Scientific Opens New Biomarker Translational Center
Goal is to accelerate MS-based biomarker discovery and its translation into development of routine clinical assays.
Wednesday, September 07, 2011
Thermo Scientific Broadens Portfolio of Single-use Laboratory Products
Acquisition of Sterilin expands Thermo Scientific consumables offering for microbiology, life science and clinical markets.
Friday, May 20, 2011
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!